Prisons skimp on Covid treatments like Paxlovid, even as Biden plans to flood pharmacies with it
WASHINGTON – Pfizer’s antiviral drug Paxlovid seems tailor-made for combatting Covid-19 in prisons: It doesn’t…
Author: STAT
STAT+: A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests
For Soung Luy, it seemed easy: His primary care doctor told him he needed blood…
Florida’s decision on Covid vaccines for healthy kids adds to confusion and distrust
Florida Surgeon General Joseph Ladapo announced Monday that the state will recommend that healthy children…
STAT+: FDA effort to improve clinical trial diversity failed to make a difference for Black patients, study finds
Six years ago, the U.S. Food and Drug Administration launched a five-year action plan to…
STAT+: Key Democrat moves to crack down on FDA accelerated approvals
WASHINGTON – A powerful Democratic lawmaker has introduced a bill that would dramatically rein in…
.jpg)
STAT+: Few public biotech companies disclose environmental, social, and governance steps
Environmental, social, and governance issues are gaining greater attention among investors, but only 30% of…
Newly discovered brain cells may be a memory filing system, study suggests
A scientist opens a laptop in front of a patient. On screen, a boy, tied…
‘We’re all in this together’: As long Covid studies continue, researchers cast a wider net
There are almost as many questions about long Covid as there are symptoms. From the…
STAT+: Pharmalittle: White House bid for Covid drug funding hurt by transparency issue; Bluebird Bio runs short of cash
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: A key study of Gilead’s breast cancer drug meets goal, but withheld data raise doubts
Gilead Sciences said Monday that a large clinical trial of its drug Trodelvy achieved its…
Public health experts sketch a roadmap to get from the Covid pandemic to the ‘next normal’
A new report released Monday charts a path for the transition out of the Covid-19…
STAT+: With cash running short, Bluebird Bio and its gene therapies face uncertain future
Bluebird Bio, the troubled developer of gene therapies, has warned that cash is running short,…
Opinion: Politicians should not be deciding what constitutes good medicine
Most people get their medical advice from their doctors. But many may soon get it…
Opinion: Sunsetting medical license reciprocity would return medicine to the dark ages
Like many other 3-year-old boys, Braxton Davis is lively and at times playfully mischievous. But…
Doctors, companies push to keep looser, pandemic-era rules for prescribing opioid addiction treatment via telemedicine
WASHINGTON — It got a lot easier for patients with opioid addiction to get their…
Women see more adverse events with chemotherapy and newer cancer treatments, study finds
When Crystal Ortner was diagnosed with stage 4 colon cancer, her doctors decided to tackle…
STAT+: Researchers question whether Amazon’s partnership with Teladoc will really improve access to health care
Amazon and Teladoc have pitched a new feature letting millions of consumers call doctors directly…
STAT+: An international treaty is needed to prevent countries from banning exports of medical products, experts urge
Amid increasing concern over shortages of medical products, a new study recommends that the United…
STAT+: ViiV causes an outcry by declining to pursue voluntary licensing for its HIV prevention shot
In a surprise move, ViiV Healthcare has decided not to license its long-acting injectable HIV…
White House transparency disputes imperil funds to buy Covid therapeutics
WASHINGTON — The White House hasn’t publicly detailed exactly how it’s spent the more than…
STAT+: Pharmalittle: Sacklers and states agree to $6 billion opioid settlement; Biogen layoffs get under way
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Microsoft closes $16B acquisition of Nuance, launching a bold experiment in health AI
AI’s next big health care experiment can now begin. Microsoft closed on a $16 billion…
Opinion: Finding cures faster: Bring the FDA into the 21st century with advanced testing
From every sector, the cry is being raised: “We can’t go back to the way…
Opinion: Health care workers don unnecessary protective gear. The CDC and WHO need to update their PPE guidance
Every time we enter a Covid patient’s room, we first don gloves, and a disposable…
‘Something is off here’: Black biotech entrepreneurs still struggle for funding as the industry pledges to diversify
SAN DIEGO — Paul Mola tried his best to keep cool. But inside, he was…
The pandemic: a series of failures, a few miracles — and a lesson for next time, global health experts say
As the nation exhales at the sight of descending curves of Covid-19 infection and death, top…
STAT+: Washington state moves closer to creating the next prescription drug affordability board
In a closely watched development, House lawmakers in Washington state passed a bill to create…
Listen: Biden’s plans for Covid pills, the latest vaccine data, & fighting about CRISPR
Is “test to treat” too good to be true? Does it really matter who gets…
STAT+: Even as it struggles, startup insurer Bright Health deepens its ties to Cigna
Bright Health is hemorrhaging money, raising questions not only about its future but also about…
Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
The Sackler family members who own Purdue Pharma have agreed to a $6 billion settlement…
STAT+: With Aduhelm in limbo, Biogen starts laying off employees
Biogen’s largest-ever corporate restructuring began Wednesday, as employees around the world got word they would…
As mental health tech heats up, startups in the space are making more exits
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: U.S. will share some coronavirus technologies with WHO; Civica Rx tries unconventional bid to make cheap insulin
Top of the morning to you, and a fine one it is. A shiny sun…
STAT+: Civica Rx has an ambitious plan to make low-cost insulin for all Americans. But can it work?
In an unconventional bid to widen access to insulin for Americans, a nonprofit announced plans…
Opinion: Inappropriate march-in actions would jeopardize public-private partnerships that make lifesaving medicines possible
For decades, partnerships among government-funded academic institutions and private companies in the United States have…
Opinion: Turning to social media to get affordable insulin: a clear sign of a broken health care system
I am part of an underground market for drugs that looks a lot different from…
STAT+: Why formally ending the pandemic is going to be a huge headache for the entire health care system
WASHINGTON — President Biden made it clear this week he wants to transition toward a…
STAT+: Awaiting ‘definitive’ Alzheimer’s drug data, Roche and Genentech launch ambitious new study
Partners Roche and Genentech are studying whether their investigational treatment for Alzheimer’s disease can prevent…
Organoids reveal the tipping point when kidney damage turns irreversible
Chronic kidney disease is a serious medical problem that changes the lives of about 13%…
STAT+: Nevada joins a little-known, ambitious state consortium dedicated to better drug prices
After months of talks, the state of Nevada has joined a consortium formed by Oregon…
As Omicron recedes, White House shifts to a more targeted Covid strategy
WASHINGTON — The threat of the Omicron variant is receding and cities around the country…
STAT+: Pharmalittle: U.S. Supreme Court examines when misprescribing is criminal; Biden calls for capping insulin at $35
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Aurinia Pharma’s takeout hopes dim with new legal challenge to key drug patent
Takeover speculation has swirled around Aurinia Pharmaceuticals since late 2019 when its lead drug, Lupkyni,…
STAT+: Vesalius Therapeutics launches to develop treatments for common diseases
Flagship Pioneering, the Cambridge, Mass., life sciences investment firm that helped found Moderna over a…
Opinion: Rediscovering a language of healing that doesn’t require ‘cure’
I am a biotech investor and entrepreneur. But more central to my worldview is that…
In a defamation lawsuit, the hype around digital health clashes with scientific criticism
A retraction often marks the end of a dispute over published scientific research. But in…
STAT+: 3 burning questions spurred by the big CRISPR patent ruling
On Monday, the U.S. Patent and Trademark Office ruled that CRISPR patents key to developing…
In State of the Union, Biden walks a fine line on Covid optimism
WASHINGTON — President Biden on Tuesday vowed that the U.S. won’t become complacent in its…
STAT+: Supreme Court debates exactly when a doctors’ misprescribing becomes criminal
Supreme Court justices on Tuesday seemed divided over where to draw the line for what…
Teladoc strikes a deal with Amazon, but may take a loss on Livongo
You’re reading the web edition of STAT Health Tech, our guide to how tech is…